TACE-Sorafenib With Thermal Ablation Has Survival Benefits in Patients With Huge Unresectable Hepatocellular Carcinoma

TACE-Sorafenib With Thermal Ablation Has Survival Benefits in Patients With Huge Unresectable Hepatocellular Carcinoma

PurposeTo investigate the effectiveness and safety of transarterial chemoembolization (TACE) combined with sorafenib and thermal ablation in patients with huge hepatocellular carcinoma (HCC).Materials and MethodsThis retrospective study examined 50 patients with huge unresectable HCC treated from Ja...

Full description

Bibliographic Details
Main Authors: Ying Wu, Han Qi, Fei Cao, Lujun Shen, Shuanggang Chen, Lin Xie, Tao Huang, Ze Song, Danyang Zhou, Weijun Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Pharmacology
Subjects:
hepatocellular carcinoma
transarterial chemoembolization
thermal ablation
sorafenib
treatment
drug resistance
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.01130/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.01130/full

Similar Items